These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10617131)

  • 1. Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis.
    Junaid MA; Wu G; Pullarkat RK
    J Neurochem; 2000 Jan; 74(1):287-94. PubMed ID: 10617131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase.
    Ezaki J; Tanida I; Kanehagi N; Kominami E
    J Neurochem; 1999 Jun; 72(6):2573-82. PubMed ID: 10349869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
    Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
    Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific substrate for CLN2 protease/tripeptidyl-peptidase I assay.
    Junaid MA; Brooks SS; Pullarkat RK
    Eur J Paediatr Neurol; 2001; 5 Suppl A():63-8. PubMed ID: 11589010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.
    Sohar I; Sleat DE; Jadot M; Lobel P
    J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.
    Warburton MJ; Bernardini F
    J Inherit Metab Dis; 2000 Mar; 23(2):145-54. PubMed ID: 10801056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
    Vines DJ; Warburton MJ
    FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
    Ezaki J; Takeda-Ezaki M; Kominami E
    J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis.
    Junaid MA; Sklower Brooks S; Wisniewski KE; Pullarkat RK
    Clin Chim Acta; 1999 Mar; 281(1-2):169-76. PubMed ID: 10217638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
    Rawlings ND; Barrett AJ
    Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.
    Sleat DE; Donnelly RJ; Lackland H; Liu CG; Sohar I; Pullarkat RK; Lobel P
    Science; 1997 Sep; 277(5333):1802-5. PubMed ID: 9295267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.
    Lin L; Sohar I; Lackland H; Lobel P
    J Biol Chem; 2001 Jan; 276(3):2249-55. PubMed ID: 11054422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
    Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
    Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry of neuronal ceroid lipofuscinoses.
    Junaid MA; Pullarkat RK
    Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases.
    Junaid MA; Pullarkat RK
    Neurosci Lett; 1999 Apr; 264(1-3):157-60. PubMed ID: 10320038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene.
    Hartikainen JM; Ju W; Wisniewski KE; Moroziewicz DN; Kaczmarski AL; McLendon L; Zhong D; Suarez CT; Brown WT; Zhong N
    Mol Genet Metab; 1999 Jun; 67(2):162-8. PubMed ID: 10356316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis.
    Zhong N; Wisniewski KE; Hartikainen J; Ju W; Moroziewicz DN; McLendon L; Sklower Brooks SS; Brown WT
    Clin Genet; 1998 Sep; 54(3):234-8. PubMed ID: 9788728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
    Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.